Renin-angiotensin system and SARS-CoV-2 infection: there is a before and after.
作者信息
Kuster Gabriela M
机构信息
Department of Cardiology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland.
Department of Biomedicine, University Hospital Basel and University of Basel, Hebelstrasse 20, 4031 Basel, Switzerland.
出版信息
Eur Heart J. 2020 Jun 7;41(22):2128-2129. doi: 10.1093/eurheartj/ehaa451.
Abstract
摘要
相似文献
1
Renin-angiotensin system and SARS-CoV-2 infection: there is a before and after.肾素-血管紧张素系统与新型冠状病毒2感染：有一个前后对比情况。
Eur Heart J. 2020 Jun 7;41(22):2128-2129. doi: 10.1093/eurheartj/ehaa451.
2
Letter by Weir Regarding Article, "Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2".韦尔就《血管紧张素转换酶2：SARS-CoV-2受体及肾素-血管紧张素系统的调节因子：庆祝ACE2发现20周年》一文所写的信
Circ Res. 2020 Jul 3;127(2):e44-e45. doi: 10.1161/CIRCRESAHA.120.317294. Epub 2020 Jul 2.
3
Response by Gheblawi et al to Letter Regarding Article, "Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2".格布拉维等人对关于“血管紧张素转换酶2：SARS-CoV-2受体与肾素-血管紧张素系统调节剂：庆祝血管紧张素转换酶2发现20周年”一文的信件的回复
Circ Res. 2020 Jul 3;127(2):e46-e47. doi: 10.1161/CIRCRESAHA.120.317332. Epub 2020 Jul 2.
4
Is there enough evidence to discontinue the renin-angiotensin system inhibitors in patients with COVID-19?是否有足够的证据支持在新冠肺炎患者中停用肾素 - 血管紧张素系统抑制剂？
Med Hypotheses. 2020 Oct;143:109888. doi: 10.1016/j.mehy.2020.109888. Epub 2020 May 27.
5
Inhibitors of the renin-angiotensin system and SARS-CoV-2 infection.肾素-血管紧张素系统抑制剂与严重急性呼吸综合征冠状病毒2感染
Herz. 2020 Jun;45(4):323-324. doi: 10.1007/s00059-020-04920-4.
6
Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19).无症状冠状病毒感染：中东呼吸综合征冠状病毒和严重急性呼吸综合征冠状病毒2（新型冠状病毒肺炎）
Travel Med Infect Dis. 2020 May-Jun;35:101608. doi: 10.1016/j.tmaid.2020.101608. Epub 2020 Feb 27.
7
The Renin-Angiotensin system and SARS-CoV-2 infection: A role for the ACE2 receptor?肾素-血管紧张素系统与新型冠状病毒2019感染：血管紧张素转换酶2受体的作用？
J Renin Angiotensin Aldosterone Syst. 2020 Apr-Jun;21(2):1470320320926911. doi: 10.1177/1470320320926911.
8
Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).血管紧张素转化酶 2（ACE2）、严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）与 2019 冠状病毒病（COVID-19）的病理生理学。
J Pathol. 2020 Jul;251(3):228-248. doi: 10.1002/path.5471. Epub 2020 Jun 10.
9
Renin-Angiotensin System Blockade in COVID-19: Good, Bad, or Indifferent?新型冠状病毒肺炎中肾素 - 血管紧张素系统阻断：有益、有害还是无关紧要？
J Am Coll Cardiol. 2020 Jul 21;76(3):277-279. doi: 10.1016/j.jacc.2020.06.003.
10
Sound Science before Quick Judgement Regarding RAS Blockade in COVID-19.在对COVID-19中的RAS阻断进行快速判断之前的可靠科学依据。
Clin J Am Soc Nephrol. 2020 May 7;15(5):714-716. doi: 10.2215/CJN.03530320. Epub 2020 Mar 27.
引用本文的文献
1
The saga continues: is COVID-19 a cardiopulmonary disease?故事仍在继续：新冠病毒肺炎是一种心肺疾病吗？
Eur Heart J. 2020 Jun 7;41(22):2041-2044. doi: 10.1093/eurheartj/ehaa502.
本文引用的文献
1
Response by Zhang et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19".张等人对关于文章《住院使用血管紧张素转换酶抑制剂和血管紧张素 II 受体阻滞剂与 COVID-19 住院高血压患者死亡率的关联》的信件的回复
Circ Res. 2020 Jun 5;126(12):e142-e143. doi: 10.1161/CIRCRESAHA.120.317242. Epub 2020 Jun 4.
2
Renin-angiotensin-aldosterone system dysregulation and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.肾素-血管紧张素-醛固酮系统失调与严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染
Eur Heart J. 2020 Jun 7;41(22):2126-2127. doi: 10.1093/eurheartj/ehaa423.
3
Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China.中国武汉因 2019 年冠状病毒病（COVID-19）感染而住院的高血压患者中，肾素-血管紧张素系统抑制剂与严重程度或死亡风险的关系。
JAMA Cardiol. 2020 Jul 1;5(7):825-830. doi: 10.1001/jamacardio.2020.1624.
Zotero 插件